Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Polyrizon Ltd. (PLRZ : NSDQ)

• Company Description    Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel. Number of Employees: 4

• Price / Volume Information    Yesterday's Closing Price: $14.68 Daily Weekly Monthly 20 Day Moving Average: 38,981 shares Shares Outstanding: 2.08 (millions) Market Capitalization: $30.59 (millions) Beta: -1.59 52 Week High: $18.20 52 Week Low: $2.88 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 28.55% 27.60% 12 Week -7.67% -10.20% Year To Date 72.91% 66.63%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL HAPNINA ST 8 - RA`ANANA,L3 4321545 ISR ph: 972-9374-0120 fax: - ir@polyrizon-biotech.com http://www.polyrizon-biotech.com

• General Corporate Information    Officers Tomer Izraeli - Chief Executive Officer Nir Ben Yosef - Chief Financial Officer Asaf Itzhaik - Director Oz Adler - Director Liat Sidi - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: M79549206 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 2.08 Most Recent Split Date: 11.00 (0.17:1) Beta: -1.59 Market Capitalization: $30.59 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.12 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 29.03 Quick Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 29.03 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - - 12/31/25 - 13.05 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - 0.00

Powered by Zacks Investment Research ©